NCT05680558
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,774 public trials
698 recruiting studies
Lymphoma, Non-Hodgkin trial results
- Conditions
- B-cell Acute Lymphocytic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +20 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT07365306
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +16 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope Atlanta Cancer Center Newnan, Georgia, United States
- City of Hope at Chicago Zion, Illinois, United States
NCT05245656
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Samsung Medical Center Seoul, Gangnam-Gu, South Korea
NCT04989621
- Conditions
- Disease Attributes, Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Guangdong General Hospital Guangzhou, Guangdong, China
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
- Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
NCT07548697
- Conditions
- B-cell Non Hodgkin Lymphoma (NHL), DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +14 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT06263491
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT07097363
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Recruiting
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
NCT03523975
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- City of Hope Medical center Duarte, California, United States
- University of Michigan Ann Arbor, Michigan, United States
- The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- University of Virginia Cancer Center Charlottesville, Virginia, United States
Recruiting
Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma
NCT07545603
- Conditions
- Follicular Lymphoma Grade 3A, Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, +11 more
- Locations
-
- Beijing Cancer Hospitial Beijing, Beijing Municipality, China